vs

Side-by-side financial comparison of BAR HARBOR BANKSHARES (BHB) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $48.9M, roughly 1.5× BAR HARBOR BANKSHARES). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 27.3%). BAR HARBOR BANKSHARES produced more free cash flow last quarter ($43.5M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 15.9%).

Bar Harbor Bankshares is a U.S. regional bank holding company headquartered in Maine. It offers retail and commercial banking services including deposit products, personal and business loans, wealth management, and mortgage solutions, mainly serving customers across Maine, New Hampshire, and Vermont.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

BHB vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.5× larger
PBYI
$75.5M
$48.9M
BHB
Growing faster (revenue YoY)
PBYI
PBYI
+0.5% gap
PBYI
27.7%
27.3%
BHB
More free cash flow
BHB
BHB
$29.1M more FCF
BHB
$43.5M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
15.9%
BHB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BHB
BHB
PBYI
PBYI
Revenue
$48.9M
$75.5M
Net Profit
$11.8M
Gross Margin
69.3%
Operating Margin
30.1%
22.7%
Net Margin
24.0%
Revenue YoY
27.3%
27.7%
Net Profit YoY
6.9%
EPS (diluted)
$0.71
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHB
BHB
PBYI
PBYI
Q4 25
$48.9M
$75.5M
Q3 25
$47.5M
$54.5M
Q2 25
$34.5M
$52.4M
Q1 25
$37.9M
$46.0M
Q4 24
$38.5M
$59.1M
Q3 24
$38.6M
$80.5M
Q2 24
$37.2M
$47.1M
Q1 24
$36.4M
$43.8M
Net Profit
BHB
BHB
PBYI
PBYI
Q4 25
$11.8M
Q3 25
$8.9M
$8.8M
Q2 25
$6.1M
$5.9M
Q1 25
$10.2M
$3.0M
Q4 24
$11.0M
Q3 24
$12.2M
$20.3M
Q2 24
$10.3M
$-4.5M
Q1 24
$10.1M
$-4.8M
Gross Margin
BHB
BHB
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
BHB
BHB
PBYI
PBYI
Q4 25
30.1%
22.7%
Q3 25
23.2%
17.6%
Q2 25
21.6%
12.7%
Q1 25
33.5%
8.7%
Q4 24
35.2%
22.6%
Q3 24
35.3%
27.4%
Q2 24
34.4%
-4.6%
Q1 24
34.8%
-5.3%
Net Margin
BHB
BHB
PBYI
PBYI
Q4 25
24.0%
Q3 25
18.6%
16.2%
Q2 25
17.6%
11.2%
Q1 25
26.9%
6.5%
Q4 24
28.6%
Q3 24
31.6%
25.2%
Q2 24
27.6%
-9.6%
Q1 24
27.7%
-11.0%
EPS (diluted)
BHB
BHB
PBYI
PBYI
Q4 25
$0.71
$0.26
Q3 25
$0.54
$0.17
Q2 25
$0.40
$0.12
Q1 25
$0.66
$0.06
Q4 24
$0.71
$0.40
Q3 24
$0.80
$0.41
Q2 24
$0.67
$-0.09
Q1 24
$0.66
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHB
BHB
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$80.8M
$97.5M
Total DebtLower is stronger
$134.8M
$22.7M
Stockholders' EquityBook value
$532.5M
$130.3M
Total Assets
$4.7B
$216.3M
Debt / EquityLower = less leverage
0.25×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHB
BHB
PBYI
PBYI
Q4 25
$80.8M
$97.5M
Q3 25
$136.7M
$94.4M
Q2 25
$87.0M
$96.0M
Q1 25
$88.1M
$93.2M
Q4 24
$72.2M
$101.0M
Q3 24
$81.2M
$96.7M
Q2 24
$101.8M
$96.8M
Q1 24
$76.2M
$107.2M
Total Debt
BHB
BHB
PBYI
PBYI
Q4 25
$134.8M
$22.7M
Q3 25
$134.6M
$34.0M
Q2 25
$40.9M
$45.3M
Q1 25
$40.9M
$56.7M
Q4 24
$40.9M
$68.0M
Q3 24
$60.9M
$79.3M
Q2 24
$60.8M
$90.7M
Q1 24
$60.8M
$102.0M
Stockholders' Equity
BHB
BHB
PBYI
PBYI
Q4 25
$532.5M
$130.3M
Q3 25
$521.0M
$115.3M
Q2 25
$468.9M
$104.7M
Q1 25
$467.3M
$97.1M
Q4 24
$458.4M
$92.1M
Q3 24
$459.9M
$71.1M
Q2 24
$438.9M
$48.5M
Q1 24
$435.7M
$51.0M
Total Assets
BHB
BHB
PBYI
PBYI
Q4 25
$4.7B
$216.3M
Q3 25
$4.7B
$202.9M
Q2 25
$4.1B
$194.9M
Q1 25
$4.1B
$196.2M
Q4 24
$4.1B
$213.3M
Q3 24
$4.0B
$220.7M
Q2 24
$4.0B
$205.0M
Q1 24
$4.0B
$214.1M
Debt / Equity
BHB
BHB
PBYI
PBYI
Q4 25
0.25×
0.17×
Q3 25
0.26×
0.30×
Q2 25
0.09×
0.43×
Q1 25
0.09×
0.58×
Q4 24
0.09×
0.74×
Q3 24
0.13×
1.12×
Q2 24
0.14×
1.87×
Q1 24
0.14×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHB
BHB
PBYI
PBYI
Operating Cash FlowLast quarter
$48.3M
$14.4M
Free Cash FlowOCF − Capex
$43.5M
$14.4M
FCF MarginFCF / Revenue
88.8%
19.1%
Capex IntensityCapex / Revenue
9.8%
0.0%
Cash ConversionOCF / Net Profit
4.10×
TTM Free Cash FlowTrailing 4 quarters
$70.0M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHB
BHB
PBYI
PBYI
Q4 25
$48.3M
$14.4M
Q3 25
$16.5M
$9.7M
Q2 25
$5.3M
$14.1M
Q1 25
$9.3M
$3.6M
Q4 24
$52.4M
$15.6M
Q3 24
$23.5M
$11.0M
Q2 24
$7.1M
$1.0M
Q1 24
$8.5M
$11.2M
Free Cash Flow
BHB
BHB
PBYI
PBYI
Q4 25
$43.5M
$14.4M
Q3 25
$15.4M
$9.7M
Q2 25
$3.3M
$14.1M
Q1 25
$7.8M
$3.6M
Q4 24
$45.0M
$15.6M
Q3 24
$22.4M
$11.0M
Q2 24
$2.3M
$1.0M
Q1 24
$7.8M
FCF Margin
BHB
BHB
PBYI
PBYI
Q4 25
88.8%
19.1%
Q3 25
32.5%
17.7%
Q2 25
9.5%
26.8%
Q1 25
20.5%
7.7%
Q4 24
116.9%
26.4%
Q3 24
58.1%
13.7%
Q2 24
6.1%
2.1%
Q1 24
21.5%
Capex Intensity
BHB
BHB
PBYI
PBYI
Q4 25
9.8%
0.0%
Q3 25
2.3%
0.0%
Q2 25
5.8%
0.0%
Q1 25
4.1%
0.1%
Q4 24
19.2%
0.0%
Q3 24
2.7%
0.0%
Q2 24
12.9%
0.0%
Q1 24
1.8%
0.0%
Cash Conversion
BHB
BHB
PBYI
PBYI
Q4 25
4.10×
Q3 25
1.87×
1.10×
Q2 25
0.86×
2.41×
Q1 25
0.91×
1.21×
Q4 24
4.76×
Q3 24
1.93×
0.54×
Q2 24
0.69×
Q1 24
0.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons